Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy | 2 | 2020 | 681 | 0.570 |
Why?
|
| Armed Conflicts | 1 | 2016 | 7 | 0.520 |
Why?
|
| Immunotherapy, Adoptive | 4 | 2025 | 832 | 0.470 |
Why?
|
| Melanoma | 1 | 2020 | 944 | 0.390 |
Why?
|
| Education, Medical | 1 | 2016 | 289 | 0.390 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 862 | 0.390 |
Why?
|
| Students, Medical | 1 | 2016 | 355 | 0.370 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 677 | 0.350 |
Why?
|
| Pneumonia | 2 | 2023 | 325 | 0.320 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 539 | 0.260 |
Why?
|
| Roseolovirus Infections | 1 | 2024 | 33 | 0.220 |
Why?
|
| Herpesvirus 6, Human | 1 | 2024 | 58 | 0.220 |
Why?
|
| Virus Activation | 1 | 2024 | 87 | 0.220 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 1659 | 0.200 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 141 | 0.190 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 183 | 0.190 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 150 | 0.190 |
Why?
|
| Anorexia | 1 | 2021 | 24 | 0.190 |
Why?
|
| Hematologic Neoplasms | 1 | 2025 | 286 | 0.190 |
Why?
|
| Hydrazines | 1 | 2021 | 30 | 0.190 |
Why?
|
| Antiemetics | 1 | 2021 | 22 | 0.190 |
Why?
|
| Myeloproliferative Disorders | 1 | 2022 | 87 | 0.180 |
Why?
|
| Nausea | 1 | 2021 | 85 | 0.180 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 139 | 0.180 |
Why?
|
| Vomiting | 1 | 2021 | 104 | 0.180 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2022 | 115 | 0.170 |
Why?
|
| Triazoles | 1 | 2021 | 139 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 348 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2020 | 174 | 0.150 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 543 | 0.150 |
Why?
|
| Syria | 1 | 2016 | 9 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 1206 | 0.110 |
Why?
|
| Incidence | 3 | 2024 | 3155 | 0.090 |
Why?
|
| Neoplasms | 2 | 2021 | 2806 | 0.070 |
Why?
|
| Humans | 10 | 2025 | 125744 | 0.070 |
Why?
|
| Young Adult | 3 | 2025 | 9118 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2024 | 16435 | 0.060 |
Why?
|
| Middle Aged | 4 | 2025 | 27002 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 177 | 0.050 |
Why?
|
| Aged | 3 | 2025 | 19897 | 0.050 |
Why?
|
| Dyspnea | 1 | 2022 | 152 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2022 | 325 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 483 | 0.040 |
Why?
|
| Cardiotoxicity | 1 | 2019 | 35 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 29759 | 0.040 |
Why?
|
| Recurrence | 1 | 2022 | 1421 | 0.040 |
Why?
|
| Female | 4 | 2025 | 67028 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3097 | 0.030 |
Why?
|
| Male | 3 | 2025 | 61807 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6173 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1713 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 10341 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 19478 | 0.020 |
Why?
|